Company intelligence / Profile preview

Paragraf

Somersham, Cambridgeshire, UK

Ownership: Private
Development stage: Other

Overview

Paragraf is pioneering graphene-based electronic devices, including graphene Hall sensors and field-effect transistors. Recent developments include graphene-based biosensors for CRISPR gene editing and diagnostic tests for infectious diseases.

Therapeutic areas: NephrologyInfectious Diseases
Modalities: DeviceBiosensors
Industry: Molecular Diagnostics

Partnerships

CERNRolls-RoyceCRISPR QCArcher Materials

Beyond the preview

Go deeper on Paragraf.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Paragraf.

Explore the full profile